Lario Therapeutics awarded $2.4m to advance calcium channel platform - PharmaTimes Funding from MJFF and Wellcome supports expansion into Parkinson’s and PTSD

#precisionmedicines #LarioTherapeutics #MJFF #Wellcome #Parkinsonsdisease #posttraumaticstressdisorder #PTSD #neuronalcalciumchanneldrugdiscoveryplatform #biopharmaceuticals #CaV13linkedParkinsonsdisease #TargetstoTherapiesinitiative #CaV23 #CACNA1Egene
zurl.co/HaJec